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Summary
Background Chinese men now smoke more than a third of the world’s cigarettes, following a large increase in urban 
then rural usage. Conversely, Chinese women now smoke far less than in previous generations. We assess the 
oppositely changing eﬀ ects of tobacco on male and female mortality.
Methods Two nationwide prospective studies 15 years apart recruited 220 000 men in about 1991 at ages 40–79 years 
(ﬁ rst study) and 210 000 men and 300 000 women in about 2006 at ages 35–74 years (second study), with follow-up 
during 1991–99 (mid-year 1995) and 2006–14 (mid-year 2010), respectively. Cox regression yielded sex-speciﬁ c adjusted 
mortality rate ratios (RRs) comparing smokers (including any who had stopped because of illness, but not the other 
ex-smokers, who are described as having stopped by choice) versus never-smokers.
Findings Two-thirds of the men smoked; there was little dependence of male smoking prevalence on age, but many 
smokers had not smoked cigarettes throughout adult life. Comparing men born before and since 1950, in the older 
generation, the age at which smoking had started was later and, particularly in rural areas, lifelong exclusive cigarette 
use was less common than in the younger generation. Comparing male mortality RRs in the ﬁ rst study (mid-year 
1995) versus those in the second study (mid-year 2010), the proportional excess risk among smokers (RR-1) 
approximately doubled over this 15-year period (urban: RR 1·32 [95% CI 1·24–1·41] vs 1·65 [1·53–1·79]; rural: RR 1·13 
[1·09–1·17] vs 1·22 [1·16–1·29]), as did the smoking-attributed fraction of deaths at ages 40–79 years (urban: 17% vs 
26%; rural: 9% vs 14%). In the second study, urban male smokers who had started before age 20 years (which is now 
typical among both urban and rural young men) had twice the never-smoker mortality rate (RR 1·98, 1·79–2·19, 
approaching Western RRs), with substantial excess mortality from chronic obstructive pulmonary disease (COPD RR 
9·09, 5·11–16·15), lung cancer (RR 3·78, 2·78–5·14), and ischaemic stroke or ischaemic heart disease (combined RR 
2·03, 1·66–2·47). Ex-smokers who had stopped by choice (only 3% of ever-smokers in 1991, but 9% in 2006) had little 
smoking-attributed risk more than 10 years after stopping. Among Chinese women, however, there has been a tenfold 
intergenerational reduction in smoking uptake rates. In the second study, among women born in the 1930s, 1940s, 
1950s, and since 1960 the proportions who had smoked were, respectively, 10%, 5%, 2%, and 1% (3097/30 943, 
3265/62 246, 2339/97 344, and 1068/111 933). The smoker versus non-smoker RR of 1·51 (1·40–1·63) for all female 
mortality at ages 40–79 years accounted for 5%, 3%, 1%, and <1%, respectively, of all the female deaths in these 
four successive birth cohorts. In 2010, smoking caused about 1 million (840 000 male, 130 000 female) deaths in China.
Interpretation Smoking will cause about 20% of all adult male deaths in China during the 2010s. The tobacco-attributed 
proportion is increasing in men, but low, and decreasing, in women. Although overall adult mortality rates are falling, as 
the adult population of China grows and the proportion of male deaths due to smoking increases, the annual number of 
deaths in China that are caused by tobacco will rise from about 1 million in 2010 to 2 million in 2030 and 3 million in 2050, 
unless there is widespread cessation.
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Introduction
For national disease control strategies, and for individual 
decisions about smoking, what matters is not just 
current but also future tobacco-attributed mortality 
rates. China now consumes over a third of the world’s 
cigarettes,1 but the increase is too recent for the full 
eﬀ ect of current cigarette consumption levels on the 
hazard per continuing smoker to have emerged.2,3 There 
has been a large intergenerational increase in cigarette 
smoking by young men, ﬁ rst in urban and then in rural 
areas. In contrast, there has been a large intergenerational 
decrease in smoking among women, at least until 
women born in the 1970s.4–7 So, assessment of future 
tobacco hazards must allow for urban versus rural and, 
particularly, male versus female diﬀ erences in lifelong 
smoking patterns.
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Assessment of current and future tobacco hazards must 
also allow for other changes in mortality. Communicable 
disease mortality is decreasing steeply and non-
communicable disease mortality is also decreasing, albeit 
more slowly.8,9 This health transition is continuing, so all-
cause mortality is falling in children and in adults, despite 
the net eﬀ ects of changes in smoking and in adiposity. At 
1970 Chinese rates, half would die before age 70 years 
(including 10% before age 5 plus another 10% before age 
50). At 2010 rates, however, only a quarter would die before 
age 70 years (including only 1% before age 5 plus another 
4% before age 50).9 These improvements are likely to 
continue (except perhaps in male smokers), due to better 
treatment and reductions in many other causes of disease.
The Chinese population has stabilised below age 50, 
but at ages 60–79 years it will double from 2010 to 2030, 
then stabilise.10 The rising over-50 population and 
falling age-speciﬁ c death rates aﬀ ect projections of 
tobacco-attributed mortality, and of the eventual risks for 
those smokers who, as has become usual for men in 
urban and then rural China, started substantial cigarette 
usage before age 20 years. The hazards currently seen in 
urban men who started cigarette smoking before age 
20 years are particularly important, as they foreshadow 
what nationwide smoker versus non-smoker mortality 
rate ratios (RRs) will eventually become.2,3
Successive nationally representative epidemiological 
studies, conducted some time apart, can help to monitor 
and predict trends in tobacco-attributed mortality.11–15 
We report two large studies in China, one monitoring 
deaths from 1991–99 (mid-year 1995),16 and the second 
monitoring deaths 15 years later, from 2006–14 (mid-year 
2010).17,18 Changing smoker versus non-smoker RRs 
between the two studies show how the epidemic is evolving. 
The baseline survey of the second study (which was more 
detailed than that of the ﬁ rst) yields data on intergenerational 
changes in smoking patterns among urban and rural men 
and women, and prospective follow-up of mortality yields 
the RRs associated with each pattern, including the 
particularly informative hazards among urban men who 
have smoked cigarettes since before age 20 years.
Methods
Study populations
After a pilot phase in 1990–91, the ﬁ rst nationwide 
prospective study (Chinese Prospective Smoking Study 
[CPSS]) had its main recruitment phase from April 9, to 
Dec 31, 1991, with follow-up to Dec 31, 1999 (mid-year 
1995). The second (China Kadoorie Biobank [CKB] study) 
recruited from June 25, 2004, to July 15, 2008, with 
follow-up to Jan 1, 2014 (mid-year 2010). The designs and 
methods of both studies have been described previously.16–18
In the ﬁ rst, 225  721 men were recruited from 45 study 
areas, chosen at random from 145 nationally represen-
tative Disease Surveillance Points (DSPs). A typical DSP 
monitors cause-speciﬁ c deaths in 50 000–100 000 residents 
in ﬁ ve to ten nearby residential units (groups of rural 
villages or urban street committees). In each study area 
(22 rural, 23 urban), two or three such units were randomly 
selected and all men aged 40 years or older were identiﬁ ed 
through local residential records and invited to take part; 
about four-ﬁ fths participated (including 219 893 at ages 
40–79 years). In local study clinics, trained health workers 
measured blood pressure, height, weight, and peak 
Research in context
Systematic review
Existing reviews of smoking and death in China include mainly 
studies established during the 1980s or 1990s.23,24 We searched 
PubMed for further such studies using the terms “smoking” 
AND “mortality” AND “China”, but found no large studies 
reported in English. The previous studies mainly involved 
people born before 1950 who, unlike those born more 
recently, had not smoked cigarettes persistently since early 
adulthood, or had smoked forms of tobacco (eg, pipes) that 
carry a lower risk than manufactured cigarettes. These 
previous studies could not assess directly the growing risks of 
tobacco in the present century. For, the hazards among 
smokers depend importantly not only on recent smoking 
patterns, but also on patterns in early adult life,2,13,14 and 
consumption of substantial numbers of cigarettes from early 
adulthood used to be uncommon, particularly in rural areas. 
Future hazards can be assessed only by studies of large 
numbers who have smoked cigarettes ever since early 
adulthood. Our two nationally representative studies can 
help to assess how the epidemic of smoking in mainland 
China has developed, and how it will evolve.
Interpretation
There are contrasting male and female trends. Among 
women, tobacco-attributed mortality is currently about 5%, 
3%, 1%, and <1% of all mortality in those born in the 1930s, 
1940s, 1950s, and since 1960. Female tobacco-attributed 
mortality is likely to fall as the pre-1950 generation, in which 
some women smoke, is replaced by the next generation, in 
which far fewer do so. Among men, the situation is opposite; 
the proportion of male deaths from smoking has been 
increasing, ﬁ rst in urban and then in rural areas, and already 
by 2010 tobacco accounted for a quarter of urban male deaths 
at ages 40–79 years. Among urban male smokers who started 
to smoke cigarettes (rather than other forms of tobacco) 
before age 20 years, which is the uptake pattern that is now 
typical among young men throughout China, overall 
mortality is already twice as great as among otherwise similar 
men who never smoked. As the epidemic matures, ﬁ rst in 
urban and then in rural areas, and the population grows, 
Chinese tobacco deaths will rise from about 1 million in 2010, 
to 2 million in 2030, and 3 million in 2050, unless there is 
widespread cessation. 
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expiratory ﬂ ow rate and administered a standardised 
questionnaire on demographics, education, occupation, 
smoking, drinking, diet, and self-reported medical 
history. Survey records were handwritten on paper, with 
subsequent data entry double-punched.
In the second study, 210 222 men and 302 669 women 
were recruited in 2004–08 from ten diverse locations across 
China, four urban and six rural (or semi-rural in the case of 
Suzhou). These study areas chosen from the DSPs to span a 
range of socioeconomic levels, risk factor patterns, and 
disease patterns. The set of all DSPs is nationally 
representative, and after excluding a few with organisational 
diﬃ  culties, the choice of ten study sites from the remaining 
DSPs was made centrally, knowing local characteristics and 
cause-speciﬁ c death rates. The exact choice of areas was 
decided carefully, aiming successfully to retain geographic 
and social balance and balance across deciles of mortality 
from major diseases, so the set of ten study sites should 
still be approximately nationally representative. All 
1 801 167 registered residents of age 35–74 years were 
identiﬁ ed through local records and invited to survey clinics, 
and 500 223 (28%) participated; another 12 668 just outside 
this age range also participated. As a substantial minority of 
registered residents would actually have been living 
elsewhere, we estimate that about a third of the invitees 
actually living in the study areas participated. Trained health 
workers took blood for long-term storage; measured height, 
weight, waist, hips, bioimpedance, blood pressure, heart 
rate, and lung function; and administered laptop-based 
questionnaires on tobacco, alcohol, diet, indoor air pollution, 
physical activity, education, socio-demographic status, 
medical history, and female reproductive history.17
Assessment of smoking
In both studies, questions about smoking included 
frequency, type, amount (current and past), age ﬁ rst began, 
age stopped, and main reason for cessation (already ill or 
stopped by choice), with additional information in the 
second study on inhalation and exhaled CO (MicroCO 
meter, Carefusion, San Diego, CA, USA).19 Regular 
smokers used one or more cigarettes (or ≥1 g tobacco) daily 
for at least 6 months. Of smokers who had stopped 
(≥6 months), about half had done so because they were ill, 
and (to avoid bias) were still counted with smokers in the 
main analyses; the remainder, who are described as having 
stopped by choice, helped assess the eﬀ ects of cessation.
Mortality follow-up
Cause-speciﬁ c mortality in both studies was monitored 
through DSP death registries,20 and checked annually 
against local residential records, with active conﬁ rmation 
of survival through street committees or village 
administrators.18 In the second study, deaths were also 
monitored through the new nationwide health insurance 
system (yielding few additional cases). Causes were 
checked against any available medical records. For the 
few deaths (about 5% in both studies) without recent 
medical attention, standardised procedures determined 
probable causes from symptoms or signs described by 
informants (usually family). Deaths were coded by 
trained staﬀ , blind to baseline data, using International 
Classiﬁ cation of Diseases (ICD)-9 in the ﬁ rst study and 
ICD-10 in the second (appendix p 3). At ages 40–79 years, 
each study had about 25 000 deaths.
Statistical analysis
Cox regression yielded multi-covariate-adjusted smoker 
versus never-smoker RRs at ages 40–79 years. Pack-years 
were not used, as ten cigarettes per day for 40 years may 
have eﬀ ects very diﬀ erent from those of 20 cigarettes per 
day for 20 years. Analyses were stratiﬁ ed for location 
(ﬁ rst study 45 areas, second study ten areas) and 5-year 
age-at-risk groups, and adjusted for education (tertiary, 
secondary, primary, or none completed) and alcohol 
consumption (never, occasional, or ever-regular).
The RR for each smoking category is accompanied by a 
CI derived only from the variance of the log risk in that 
one category. Hence, each RR, including that for the 
reference group, is associated with a group-speciﬁ c CI 
that can be thought of as reﬂ ecting the amount of data 
only in that one category.21 The 95% group-speciﬁ c CI for 
RR is (RR/T, RR×T), where T=exp (1·96√v) and v is the 
variance of the log risk. 
If the reference group with RR=1 and another group 
with RR=R have, respectively, group-speciﬁ c CIs (a, b) 
and (x, y), then the CI for R that allows for the variation 
in both of the groups is (√ [xy/k], √ [xyk]), where log (k) is 
given by √(log2 [y/x] + log2 [b/a]); since k>y/x, this CI is 
wider than (x, y). 
Figure 1: Chinese female smoking uptake rate by year of birth and locality
300 000 women seen in ten study areas in about 2006, with birth years grouped 
as: before 1935, 1935–44, 1945–54, 1955–64, and 1965 or later. The two areas 
where many older women smoked are in Harbin (urban northeast China) and 
Sichuan (rural southwest China). Taking all ten areas together, the prevalences of 
ever-smoking among women born in the 1930s, 1940s, 1950s, 1960s, and 
1970s were, respectively, 10%, 5%, 2%, 1%, and <1% (3097/30 943, 3265/62 246, 
2339/97 344, 926/94 772, and 142/17 161).
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If RR is causal, the fraction of all deaths in the 
population that is attributed to smoking (ie, the 
population-attributed fraction; PAF) is P(RR-1) divided by 
RR, P being the prevalence of smoking among those 
dying of the relevant cause.22 Setting P=1 yields (RR–1) 
divided by RR, the fraction of the mortality among 
smokers that is attributed to smoking. Analyses used SAS 
version 9.3.
Role of the funding sources
The funders of the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the report. ZC, RP, and LL had full access to all 
the data in the study and had ﬁ nal responsibility for the 
decision to submit for publication.
Results
Women were included only in the second study. Of 
302 669 women enrolled in 2004–08, only 3·2% were ever 
regular smokers, including 0·5% who stopped by choice. 
Smoking uptake decreased steeply across successive 
generations of women. Hence, there were much lower 
prevalences among those born in more recent decades 
(ﬁ gure 1). Taking all study areas together, the prevalences 
of smoking among women born in the 1930s, 1940s, 1950s, 
and since the 1960s were 10%, 5%, 2%, and 1% (see ﬁ gure 1 
legend). In most locations, few women smoked, although 
in urban Harbin (northeast China) and rural Sichuan 
(southwest China), appreciable numbers of older women 
did so. Both in these two locations and elsewhere, the 
prevalence was about tenfold lower in women born in the 
Figure 2: Urban and rural Chinese male smoking patterns, by year of birth—prevalence, consumption, age started, and tobacco type smoked initially
210 000 men seen in about 2006 (at the 2004–08 baseline survey for the second prospective study). Prevalence of smoking (A); amount smoked per day when last 
smoked (B); Mean age started smoking regularly (C); and percentage of all smokers who used cigarettes when ﬁ rst started (D). To avoid reverse causality biasing the 
apparent eﬀ ects of smoking and of cessation, in panel (A) and in the main analyses, the few men who had stopped smoking because they were ill are combined with 
the continuing smokers, leaving the ex-smokers who had stopped by choice. The overall proportions of men who had stopped because they were ill were 2·16%, 2·47%, 
2·19%, 1·08% and 0·12% for those born during the 1930s, 1940s, 1950s, 1960s, and 1970s respectively. 
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1960s (age about 40 years in 2006) than in women born in 
the 1930s (age about 70 years in 2006). On average, female 
smokers had started at age 27 years and currently smoked 
about 10 g/day (ten cigarette equivalents/day, though not 
necessarily as cigarettes).
During 2·0 million woman-years of follow-up (mid-year 
2010), 9934 women died at ages 40–79 years. Female 
mortality rates were signiﬁ cantly related to smoking for all 
causes (RR 1·51, 1·40–1·63) and for lung cancer, ischaemic 
heart disease, and chronic obstructive pulmonary disease 
(COPD) (appendix p 4).The proportional increase in overall 
mortality among smokers was greater in urban (RR 1·72, 
1·52–1·96) than in rural (RR 1·40, 1·27–1·54) women, but 
numbers were too small for subdivision by smoking 
patterns. If these associations are causal, then about a third 
(0·51/1·51) of all deaths of female smokers were due to 
tobacco. As, however, few women smoked, the fraction of 
female mortality attributed to smoking was only 3% for 
deaths at ages 40–79 years (and 1·1%, 2·7%, and 5·2% for 
deaths at ages 40–59, 60–69, and 70–79 years). This 
dependence on age can also be expressed in terms of 
decade of birth: smoking caused about 5%, 3%, 1%, and 
less than 1% of all deaths among Chinese women born in 
the 1930s, 1940s, 1950s, and since 1960. The prevalences of 
smoking in these four birth cohorts were 10%, 5%, 2%, 
and 1%, respectively.
Among men, the smoking patterns were very diﬀ erent. 
The ﬁ rst of these two prospective studies began about 
Breath 
CO, ppm
All causes Lung cancer Ischaemic stroke or ischaemic 
heart disease
COPD
Number 
of deaths
RR* 
(95% group-speciﬁ c CI)
Number 
of deaths
RR* 
(95% group-speciﬁ c CI)
Number 
of deaths
RR* 
(95% group-speciﬁ c CI)
Number 
of deaths
RR* 
(95% group-speciﬁ c CI)
Urban men, about 2010 (2006–14)
Age started smoking (mean), years
Age <20 (16·9) 16·5 843 1·98 (1·85–2·13) 127 3·78 (3·15–4·54) 200 2·03 (1·75–2·35) 43 9·09 (6·60–12·50)
Age 20–24 (21·0) 15·2 797 1·61 (1·50–1·73) 127 3·17 (2·67–3·77) 182 1·50 (1·30–1·74) 24 3·89 (2·62–5·79)
Age ≥25 (30·4) 12·6 754 1·44 (1·34–1·55) 96 2·23 (1·82–2·73) 196 1·49 (1·29–1·72) 24 2·89 (1·93–4·32)
All smokers 14·9 2394 1·65 (1·59–1·73) 350 2·98 (2·66–3·33) 578 1·63 (1·49–1·77) 91 4·61 (3·71–5·71)
Non-smokers 4·5 924 1·00 (0·94–1·07) 69 1·00 (0·79–1·27) 242 1·00 (0·88–1·14) 18 1·00 (0·62–1·60)
Trend p value† <0·0001 0·0002 0·0032 <0·0001
Rural men, about 2010 (2006–14)
Age started smoking (mean), years
<20 (16·8) 15·1 2710 1·39 (1·34–1·45) 271 2·91 (2·58–3·29) 334 1·37 (1·23–1·53) 315 1·88 (1·68–2·10)
20–24 (21·2) 13·6 2788 1·26 (1·21–1·31) 275 2·45 (2·17–2·75) 397 1·35 (1·23–1·49) 261 1·41 (1·24–1·59)
≥25 (31·3) 11·8 2434 1·05 (1·01–1·10) 177 1·63 (1·41–1·90) 347 1·04 (0·93–1·16) 233 1·07 (0·94–1·22)
All smokers 13·6 7932 1·22 (1·20–1·25) 723 2·30 (2·13–2·48) 1078 1·24 (1·17–1·32) 809 1·41 (1·31–1·51)
Non-smokers 6·0 2031 1·00 (0·96–1·05) 92 1·00 (0·81–1·23) 316 1·00 (0·89–1·12) 172 1·00 (0·86–1·16)
Trend p value† <0·0001 <0·0001 0·0005 <0·0001
Urban men, about 1995 (1991–99)
Age started smoking (mean), years
<20 (16·7) ·· 1158 1·60 (1·51–1·70) 142 3·20 (2·69–3·80) 178 1·58 (1·36–1·84) 194 1·82 (1·57–2·21)
20–24 (21·2) ·· 1358 1·37 (1·30–1·44) 130 2·31 (1·95–2·75) 208 1·37 (1·19–1·57) 209 1·43 (1·25–1·64)
≥25 (30·6) ·· 1136 1·11 (1·04–1·17) 97 1·73 (1·42–2·12) 178 1·17 (1·01–1·36) 186 1·16 (1·00–1·34)
All smokers ·· 3652 1·32 (1·28–1·37) 369 2·32 (2·08–2·59) 564 1·35 (1·23–1·47) 589 1·42 (1·30–1·55)
Non-smokers ·· 1381 1·00 (0·95–1·06) 82 1·00 (0·80–1·25) 240 1·00 (0·87–1·14) 197 1·00 (0·87–1·15)
Trend p value† <0·0001 <0·0001 0·0052 <0·0001
Rural men, about 1995 (1991–99)
Age started smoking (mean), years
<20 (16·8) ·· 5107 1·20 (1·16–1·23) 236 1·98 (1·73–2·26) 435 1·12 (1·02–1·23) 1373 1·40 (1·33–1·48)
20–24 (20·9) ·· 6215 1·14 (1·11–1·17) 280 1·82 (1·62–2·05) 605 1·17 (1·08–1·27) 1573 1·28 (1·22–1·34)
≥25 (29·6) ·· 3901 1·04 (1·01–1·07) 139 1·37 (1·16–1·62) 385 1·08 (0·98–1·18) 986 1·06 (0·99–1·13)
All smokers ·· 15 223 1·13 (1·11–1·15) 655 1·76 (1·62–1·91) 1425 1·13 (1·07–1·20) 3932 1·25 (1·21–1·30)
Non-smokers ·· 4855 1·00 (0·97–1·03) 150 1·00 (0·85–1·18) 499 1·00 (0·91–1·09) 1114 1·00 (0·94–1·06)
Trend p value† <0·0001 <0·0001 0·0620 <0·0001
Group-speciﬁ c CI for the non-smoker RR of 1·00 reﬂ ects the variance of the log risk in non-smokers; for each of the other RRs the CI is correspondingly wider than the group-speciﬁ c CI. COPD=chronic obstructive 
pulmonary disease. *RRs (smokers vs non-smokers) were adjusted for 5-year age group and region, alcohol, and education; additional adjustment for occupation made no material diﬀ erence to the RRs. †Trend 
test in smokers, ignoring non-smokers; if trend tests in this table had included non-smokers, each would have yielded p<0·0001.
Table 1: Age started smoking regularly versus cause-speciﬁ c mortality rate ratio (RR) among urban and rural men in about 2010 (second study) and about 1995 (ﬁ rst study)
Articles
1452 www.thelancet.com   Vol 386   October 10, 2015
15 years before the second (1991 vs 2006), so those in it 
had, on average, an earlier year of birth (1938 vs 1954) and 
were less likely to have smoked only cigarettes when they 
started smoking, or last smoked (appendix p 5). The 
prevalences of ever-smoking among men in the 
two studies were similar, and did not depend strongly on 
age. In the second study, 68% were smokers (including 
those who had stopped because they were ill) and another 
7% were ex-smokers (described as stopping by choice). 
Figure 2, from the baseline survey for the second study, 
describes smoking patterns by birth year. Male smokers 
born in 1970 had started around age 20 years and used 
only cigarettes, but male smokers born in the 1930s (an 
earlier generation) had started around age 25 years, 
smoked other tobacco types, and (not shown) were 
slightly less likely to inhale deeply. The proportion of 
smokers who had used cigarettes throughout adulthood 
was higher in urban than in rural men.
Male deaths at ages 40–79 years numbered 25 548 in the 
ﬁ rst study and 14 241 in the second. In both, smokers’ 
mortality rates were signiﬁ cantly elevated (ﬁ rst study: 
RR 1·17, 1·14–1·21; second study: RR 1·33, 1·28–1·39; 
table 1). So, although the studies were only 15 years apart 
(mid-years of follow-up 1995 and 2010), the proportional 
excess mortality among smokers (RR-1) had approximately 
doubled. Within each study, the RRs for all-cause mortality 
were not as extreme in rural as in urban men (ﬁ rst study: 
rural RR 1·13, 1·09–1·17 and urban RR 1·32, 1·24–1·41; 
second study: rural RR 1·22, 1·16–1·29 and urban RR 1·65, 
1·53–1·79). Apart from the rural versus urban diﬀ erence, 
the RRs in the second study diﬀ ered little across study sites 
(appendix p 6). If the associations of smoking with death 
are largely causal, then the proportion of all male deaths at 
ages 40–79 years attributed to smoking rose between 1995 
and 2000 from about 11% in the ﬁ rst study (PAF 9% rural, 
17% urban) to about 18% in the second study (PAF 14% 
rural, 26% urban). If the PAF rose from 11% in 1995 to 
18% in 2010, it will be at least 20% by the mid-2010s. 
Hence, smoking will cause about 20% of all male deaths at 
ages 40–79 years during the 2010s (ie, 2010–19).
Similarly, the proportional excess mortality among 
smokers (ie, RR-1) increased substantially between 1995 
and 2010 for lung cancer (ﬁ rst study: RR 1·95, 1·68–2·26; 
second study: RR 2·58, 2·17–3·05), all vascular disease 
(ﬁ rst study: RR 1·12, 1·07–1·18; second study: RR 1·24, 
1·16–1·33), and COPD (ﬁ rst study: RR 1·28, 1·20–1·36; 
second study: RR 1·62, 1·38–1·90).
Figure 3 shows, for both studies, the urban and rural 
RRs for overall mortality by age started smoking regularly. 
In each case, men who had started before age 20 years 
(mean age 17 years) were at substantially greater risk than 
were those who had started at ages 20–24 years (mean age 
21 years). Diﬀ erences in the reported ages at which men 
had started smoking regularly did not, however, suﬃ  ce to 
explain the more extreme RRs in the second study, as even 
within each category of age started, the RR was substantially 
more extreme in the second study (table 1). 
Among urban male smokers in the second study who 
had started before age 20 years (as is now typical 
throughout urban and rural China), most had always used 
manufactured cigarettes, and their all-cause mortality rate 
was double that of non-smokers (RR 1·98, 1·79–2·19). 
This suggests that about half (0·98/1·98) of their deaths 
were due to tobacco. This proportion could well rise still 
further. The few urban men who had started before age 
15 years were at even greater risk (RR 2·64, 2·19–3·19).
The remaining analyses are given separately for urban 
and rural men in the two studies. The discussion 
particularly emphasises ﬁ ndings in the second study for 
urban smokers, among whom the RR was 1·65 (1·53–1·79) 
for all causes, 2·98 (2·28–3·89) for lung cancer, 
1·63 (1·39–1·90) for ischaemic stroke or ischaemic heart 
disease, and 4·61 (2·75–7·73) for COPD; the RRs were even 
more extreme for men who had started before age 20 years 
(table 1). Smokers also had elevated mortality from some 
other diseases (appendix p 4), including stomach and 
oesophagus cancer, which are still major causes of death in 
some parts of China. In rural men, the RRs were generally 
less extreme, especially for vascular disease and COPD.
For the same disease groupings, table 2 shows urban 
and rural RRs in both studies by amount last smoked 
(<15, 15–24 and ≥25 g/day, adding together cigarettes per 
day and g per day of tobacco). It is only the RRs (not the 
absolute mortality rates) that are compared between areas 
and studies, as in table 1. For smokers in the second 
study, among urban men there were highly signiﬁ cant 
dose-response relationships for mortality from all causes, 
lung cancer, ischaemic stroke and ischaemic heart disease 
(each trend p<0·0001), and COPD (trend p=0·0021), but 
in rural men, the dose-response relationships among 
smokers (ignoring the non-smokers) were signiﬁ cant 
only for lung cancer, a disease with little time between 
symptom onset and death. The lack of a dose-response 
relationship for COPD (a major cause of death in rural 
Figure 3: All-cause smoker versus never-smoker mortality rate ratio (RR) among urban and rural Chinese men 
in two prospective studies, by time period (about 1995 or about 2010) and by age started smoking regularly
Each study followed about 200 000 men. Each group-speciﬁ c CI (including that for never-smokers, given by the 
width of the shaded strip) reﬂ ects the variance of the log risk in that one group, so comparisons of RRs use variances 
from more than one group. 
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areas) may reﬂ ect biases from reverse causality, whereby 
COPD symptoms could reduce the amount smoked. For 
all four disease groupings, tests for trend that included 
the never-smokers as having zero dose were highly 
signiﬁ cant in urban and rural areas in both studies 
(16 trend tests each p<0·0001; table 2).
The proportion of male smokers who had stopped by 
choice rose appreciably over the 15 years from 1991 to 
2006, from only 3% (4306/160 971) in the ﬁ rst baseline 
survey to 9% (14 080/156 313) in the second, and 
stopping by choice avoided nearly all the excess risk that 
would have been seen at the mortality rates of 
continuing smokers (ﬁ gure 4). Among ex-smokers who 
had stopped by choice, the RR for all-cause mortality 
was 1·02 (0·95–1·10), and it attenuated with quitting 
duration. For men who had stopped by choice less than 
5 years, 5–14 years, and 15 or more years before baseline, 
the RRs were 1·21 (1·07–1·37), 1·00 (0·90–1·11), and 
0·98 (0·87–1·11) (trend p=0·01). These ﬁ ndings were 
not materially changed by inclusion of the ﬁ rst-study 
results (appendix p 7). Numbers who stopped by choice 
and died from speciﬁ c conditions were too small for 
separate analysis. Among men who had stopped 
because they were already ill, the protective eﬀ ects of 
quitting cannot be assessed straightforwardly. For, even 
if cessation is substantially protective, the illness that 
had made them stop could still cause them to be at 
misleadingly elevated risk (ﬁ gure 4).
 Breath 
CO, ppm
All causes Lung cancer Ischaemic stroke or ischaemic 
heart disease
COPD
Number 
of deaths
RR* 
(95% group-speciﬁ c CI)
Number 
of deaths
RR* 
(95% group-speciﬁ c CI)
Number 
of deaths
RR* 
(95% group-speciﬁ c CI)
Number 
of deaths
RR* 
(95% group-speciﬁ c CI)
Urban men, about 2010 (2006–14)
Daily amount smoked (mean)
<15 (8·3) 12·0 890 1·48 (1·39–1·59) 115 2·28 (1·90–2·74) 209 1·36 (1·19–1·56) 26 2·94 (1·99–4·35)
15–24 (19·2) 16·2 1091 1·70 (1·60–1·80) 167 3·28 (2·82–3·83) 261 1·73 (1·53–1·96) 45 5·40 (4·04–7·23)
≥25 (34·9) 17·6 413 1·93 (1·75–2·12) 68 4·12 (3·24–5·24) 108 2·24 (1·85–2·71) 20 7·26 (4·66–11·32)
All smokers 14·9 2394 1·65 (1·59–1·73) 350 2·98 (2·66–3·33) 578 1·63 (1·49–1·77) 91 4·61 (3·71–5·71)
Non-smokers 4·5 924 1·00 (0·94–1·07) 69 1·00 (0·79–1·27) 242 1·00 (0·88–1·14) 18 1·00 (0·62–1·60)
Trend p value† <0·0001 <0·0001 <0·0001 0·0021
Rural men, about 2010 (2006–14)
Daily amount smoked (mean)
<15 (7·7) 12·1 3298 1·25 (1·20–1·29) 202 1·81 (1·57–2·09) 537 1·27 (1·16–1·39) 347 1·52 (1·36–1·70)
15–24 (19·3) 14·5 3113 1·17 (1·13–1·22) 333 2·38 (2·14–2·65) 380 1·14 (1·03–1·27) 306 1·32 (1·18–1·47)
≥25 (35·3) 14·0 1521 1·27 (1·20–1·34) 188 3·20 (2·75–3·72) 161 1·37 (1·16–1·61) 156 1·34 (1·13–1·59)
All smokers 13·6 7932 1·22 (1·20–1·25) 723 2·30 (2·13–2·48) 1078 1·24 (1·17–1·32) 809 1·41 (1·31–1·51)
Non-smokers 6·0 2031 1·00 (0·96–1·05) 92 1·00 (0·81–1·23) 316 1·00 (0·89–1·12) 172 1·00 (0·86–1·16)
Trend p value† 0·7875 <0·0001 0·9951 0·1126
Urban men, about 1995 (1991–99)
Daily amount smoked (mean)
<15 (8·2) ·· 1332 1·23 (1·16–1·30) 104 1·77 (1·46–2·15) 202 1·22 (1·06–1·40) 223 1·28 (1·12–1·46)
15–24 (19·2) ·· 1660 1·35 (1·29–1·42) 190 2·62 (2·27–3·03) 261 1·40 (1·24–1·59) 256 1·45 (1·28–1·64)
≥25 (36·1) ·· 660 1·51 (1·39–1·63) 75 2·80 (2·21–3·53) 101 1·55 (1·27–1·89) 110 1·78 (1·46–2·15)
All smokers ·· 3652 1·32 (1·28–1·37) 369 2·32 (2·08–2·59) 564 1·35 (1·23–1·47) 589 1·42 (1·30–1·55)
Non-smokers ·· 1381 1·00 (0·95–1·06) 82 1·00 (0·80–1·25) 240 1·00 (0·87–1·14) 197 1·00 (0·87–1·15)
Trend p value† <0·0001 0·0015 0·0389 0·0071
Rural men, about 1995 (1991–99)
Daily amount smoked (mean)
<15 (8·9) ·· 3959 1·16 (1·09–1·16) 132 1·37 (1·15–1·63) 434 1·10 (1·00–1·21) 1005 1·25 (1·17–1·33)
15–24 (18·8) ·· 6886 1·13 (1·10–1·15) 327 1·90 (1·70–2·12) 659 1·18 (1·09–1·28) 1800 1·23 (1·18–1·29)
≥25 (36·5) ·· 4378 1·13 (1·10–1·17) 196 1·84 (1·58–2·13) 332 1·08 (0·97–1·21) 1127 1·29 (1·22–1·38)
All smokers ·· 15 223 1·13 (1·11–1·15) 655 1·76 (1·62–1·91) 1425 1·13 (1·07–1·20) 3932 1·25 (1·21–1·30)
Non-smokers ·· 4855 1·00 (0·97–1·03) 150 1·00 (0·85–1·18) 499 1·00 (0·91–1·09) 1114 1·00 (0·94–1·06)
Trend p value† 0·7163 0·0233 0·8946 0·4014
Daily amount smoked adds together cigarettes plus g of other tobacco. Group-speciﬁ c CI for the non-smoker RR of 1·00 reﬂ ects the variance of the log risk in non-smokers. COPD=chronic obstructive pulmonary 
disease. *RRs (smokers vs non-smokers) were adjusted for 5-year age group and region, alcohol, and education; additional adjustment for occupation made no material diﬀ erence to the RRs. †Trend test in 
smokers, ignoring non-smokers; if trend tests in this table had included non-smokers, each would have yielded p<0·0001.
Table 2: Amount last smoked versus cause-speciﬁ c mortality rate ratio (RR) among urban and rural men in about 2010 (second study) and about 1995 (ﬁ rst study)
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The smoker versus non-smoker RRs for lung cancer in 
these studies are much less extreme than in recent US 
prospective studies (appendix p 8–10), but the absolute 
excess lung cancer mortality in Chinese smokers is still 
substantial, as Chinese people have much higher non-
smoker lung cancer rates than Americans do, especially 
in later middle age.3 Within China, never-smoker lung 
cancer rates fell slightly between the two prospective 
studies, whereas the smokers’ lung cancer rates rose, 
resulting in greater RRs in the second study. 
Discussion
Among Chinese men, tobacco-attributed mortality has 
grown considerably since the 1990s, and during the 2010s, 
smoking will cause about 20% of all male deaths at ages 
40–79 years, up from only about 10% in the early 1990s. 
Moreover, the mortality rate ratio of 2 already seen among 
urban male smokers who started before age 20 years (the 
uptake pattern now typical in both urban and rural China) 
suggests that about half of these men’s deaths were 
caused by smoking. This mortality rate ratio of 2 is still 
increasing, foreshadowing substantially greater future 
hazards for Chinese men (panel). Also, although this was 
not assessed in the present report, tobacco causes many 
non-fatal disease episodes, and much disability.
Among Chinese women, however, tobacco-attributed 
mortality is much smaller, and is currently still falling. 
Fewer women than men are smokers, and there was a 
large intergenerational decrease in the female prevalence 
of smoking, from about 10% among women born in the 
1930s down to only about 1% among women born around 
1970, which has been conﬁ rmed in an independent 
nationwide survey.6 Hence, although the present study 
suggests that the hazard per smoker is comparable for 
men and women, as did previous studies,13,14,23 tobacco-
attributed mortality in the entire female population is low, 
and will fall further by 2030 as the present generation of 
women in which few smoke is succeeded by a generation 
in which even fewer smoke. (A recent WHO report 
mistakenly suggested, using methods3 inappropriate 
for China, that male and female tobacco-attributed 
proportions of deaths are similar;24 this is impossible, 
given the 20-fold diﬀ erence in smoking prevalence.) But, 
this favourable trend may cease (with women born 
around 1980 and now in their thirties being the least 
exposed generation), as tobacco use by adolescent females 
has recently begun to increase in some parts of China.7 
This underlines the danger that, as in many Western 
countries, social changes may well lead young Chinese 
women to start smoking. It will, however, take decades, 
probably until after 2050, for an increase in female 
smoking to  cause a substantial increase in mortality, and 
over the next 20 years, while tobacco-attributed deaths 
increase among Chinese men, they should decrease 
among Chinese women, perhaps from about 3% of all 
female deaths now to less than 1% by the 2030s.2
A few large studies have provided reasonably robust 
evidence about the hazards of smoking in speciﬁ c 
Chinese male populations, but most of the people who 
died in them were born before 1950,16,25–29 so the smokers 
were at limited risk, as in the USA 60 years ago.11,14 Some 
studies29,30 have attempted to assess the extent of the 
Chinese epidemic in the early 2000s, but they involved 
cohorts established decades ago of men born before 
1950, or used data from atypical regions (eg, Shanghai) 
where manufactured cigarettes have long been available.31
In China, cigarette consumption became widespread 
earlier in urban than in rural areas, mainly because of 
limited rural availability (and, until recent decades, 
aﬀ ordability) of cigarettes.32 Hence, the hazard associated 
with a given current smoking pattern is more extreme in 
urban than in rural areas. However, this urban versus 
rural diﬀ erence is likely to diminish, or even be reversed, 
over the next few decades, because rural men born after 
the 1960s not only tended to start at the same age as urban 
men and to smoke only cigarettes, but also had a 
somewhat higher smoking prevalence (ﬁ gure 2). As 
earlier generations of urban and rural men get replaced 
by generations who have smoked cigarettes persistently 
since early adulthood, tobacco-attributable risks in middle 
age may soon reach those seen in many Western 
populations, as has almost happened in the subgroup of 
urban men who started smoking before age 20 years in 
the present study (and in Hong Kong, where cigarette use 
peaked about 20 years earlier than in mainland China33).
For the chief diseases by which tobacco causes death, 
there are large quantitative diﬀ erences between China 
and elsewhere, between urban and rural China, and 
between past and future decades.2 In many Western 
Figure 4: Ex-smoker versus never-smoker all-cause mortality rate ratio (RR), by 
years stopped smoking and reason stopped, for men in the second study
Each group-speciﬁ c CI (including that for never-smokers, given by the width of the 
shaded strip) reﬂ ects the variance of the log risk in that 1 group, so comparisons 
use variances from more than one group. 
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populations, tobacco used to cause far more deaths from 
vascular than from respiratory disease,11–15 whereas in 
China the opposite is true, especially in rural areas. 
Although the RRs for COPD, lung cancer, and stroke 
may at present be smaller than in many Western 
populations, the absolute risks associated with smoking 
are not, as Chinese non-smoker death rates are high. 
Indeed, 1980s lung cancer mortality among Chinese 
never-smokers was more than three times that in US 
never-smokers, perhaps due partly to indoor air pollution 
from heating and cooking.2 While US never-smoker lung 
cancer rates have remained roughly constant over the 
past half-century,3 those in Chinese never-smokers seem 
to be decreasing while those in smokers are increasing, 
causing increasing smoker versus non-smoker lung 
cancer mortality rate ratios.
Absolute mortality rates are likely to be lower in 
prospective studies than in the general population. Hence, 
to estimate absolute numbers of tobacco-attributed deaths 
in China in 2010, the smoking-attributed fractions of all 
deaths in our second prospective study have been applied 
to independent estimates of male and female cause-
speciﬁ c numbers of deaths in mainland China34 at ages 
35–69, 70–79, and 80 years or older (appendix p 4). This 
shows that there were about 1 million smoking-attributed 
deaths in 2010 (840 000 male, 130 000 female; table 3), 
mainly from diseases already known to be aﬀ ected by 
smoking (lung cancer, ischaemic heart disease, ischaemic 
stroke, COPD, and other neoplastic, vascular, and 
respiratory conditions).3,11 Counterbalancing the increasing 
RRs for all-cause mortality, age-speciﬁ c under-70 mortality 
rates in China are decreasing due to many social, 
occupational and health-care changes, falling by about 
15% during 2000–10,9 so the absolute death rate from 
smoking is not increasing as fast as would be suggested 
just by the increasing RRs.
About two-thirds of young Chinese men become 
cigarette smokers in early adult life. Unless they stop, the 
present study suggests that at least half of them will 
eventually be killed by their habit, and future studies may 
well show that a somewhat greater proportion will be 
killed by it. The ﬁ rst generation of men to experience the 
full hazards will probably be those born during the 1970s 
or 1980s, who reached adulthood when nationwide 
cigarette consumption was high. Conversely, this may 
well be the least exposed female generation.
China’s 2030 sustainable development goals include 
reducing non-communicable disease mortality by a third, 
and monitoring the changes. If current smoking patterns 
persist, then as the smoker versus non-smoker RRs 
increases, mortality from other causes decreases, and the 
over-60 population doubles, Chinese tobacco deaths are 
likely to rise from 1 million in 2010 to about 2 million in 
2030. Nowadays, in China more than 6 million young 
men a year begin smoking. If most persist, and (as in the 
USA14 and UK12,13) smokers eventually have more than 
double the non-smoker mortality rates, there will in 2050 
be about 3 million Chinese tobacco deaths, when those 
born in 1970 reach age 80 years. Although continuation 
of our second prospective study will monitor how the 
epidemic develops over the next decade or two, large new 
prospective studies of people born after 1970 will be 
needed to continue monitoring it thereafter. Fortunately, 
China’s nationally representative household surveys 
regularly record smoking and the reasons for smoking 
cessation, and electronic linkage of this information with 
routine mortality records should allow reliable 
monitoring of the evolution of the epidemic for many 
decades to come.
Avoiding uptake of smoking by young people will 
greatly reduce tobacco deaths in the second half of the 
century. Moreover, stopping before the onset of 
life-threatening illness is remarkably protective, and an 
increasing proportion of smokers have stopped by 
choice (9% in 2006 vs only 3% in 1991). With eﬀ ective 
measures to accelerate cessation, the growing epidemic 
of premature death from tobacco can be halted and then 
reversed, as in other countries. Widespread smoking 
cessation oﬀ ers China one of the most eﬀ ective, and 
cost-eﬀ ective,35 strategies to avoid disability and 
premature death over the next few decades.
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